Symbols / GRTS
GRTS Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2024-08-13 16:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | $0.00 |
| Price | $0.03 | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-10-02 | down | Jones Trading | Buy → Hold | — |
| 2024-10-02 | down | B. Riley Securities | Buy → Neutral | $1 |
| 2024-10-01 | down | HC Wainwright & Co. | Buy → Neutral | $1 |
| 2024-10-01 | down | JMP Securities | Market Outperform → Market Perform | — |
| 2024-08-15 | reit | HC Wainwright & Co. | Buy → Buy | $4 |
| 2024-08-05 | reit | JMP Securities | Market Outperform → Market Outperform | $5 |
| 2024-08-05 | reit | HC Wainwright & Co. | Buy → Buy | $4 |
| 2024-06-14 | reit | JMP Securities | Market Outperform → Market Outperform | $5 |
| 2024-05-24 | reit | B. Riley Securities | Buy → Buy | $3 |
| 2024-05-13 | main | HC Wainwright & Co. | Buy → Buy | $4 |
| 2024-04-02 | main | JMP Securities | Market Outperform → Market Outperform | $5 |
| 2024-03-06 | reit | HC Wainwright & Co. | Buy → Buy | $7 |
| 2024-02-28 | init | JMP Securities | — → Market Outperform | $4 |
| 2023-09-28 | main | Piper Sandler | Overweight → Overweight | $7 |
| 2023-08-10 | reit | HC Wainwright & Co. | Buy → Buy | $7 |
| 2023-05-15 | reit | HC Wainwright & Co. | Buy → Buy | $7 |
| 2023-03-28 | init | B. Riley Securities | — → Buy | $8 |
| 2023-03-14 | reit | HC Wainwright & Co. | — → Buy | $7 |
| 2023-02-15 | main | HC Wainwright & Co. | — → Buy | $7 |
| 2022-11-07 | main | HC Wainwright & Co. | — → Buy | $7 |
- Gritstone bio’s Stock Is on a Knife Edge: Can New Cancer and Vaccine Bets Rescue GRTS? - AD HOC NEWS Sat, 14 Feb 2026 19
- Gritstone Oncology Pursues Restructuring Through Chapter 11 - Yahoo Finance Fri, 11 Oct 2024 07
- The Truth About Gritstone bio (GRTS): Tiny Vaccine Stock, Massive Hype? - AD HOC NEWS Sat, 07 Feb 2026 08
- Class Action Lawsuit Against Gritstone Bio, Inc. (NASDAQ:GRTS) - Nasdaq ue, 30 Jul 2024 07
- Gritstone bio announces layoffs and Nasdaq delisting - Investing.com Wed, 16 Oct 2024 07
- Gritstone (GRTS) Plummets 58% in a Week: Here's Why - Nasdaq hu, 04 Apr 2024 07
- Gritstone bio: GRANITE Cancer Vaccine Data Overshadowed By Offering (NASDAQ:GRTS) - Seeking Alpha Sun, 07 Apr 2024 07
- Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure - Business Wire hu, 10 Oct 2024 07
- StockWatch: Wave’s RNA Editing Milestone Lifts Korro, ProQR - GEN - Genetic Engineering and Biotechnology News Sun, 20 Oct 2024 07
- Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday - InvestorPlace hu, 28 Sep 2023 07
- Pharma and biotech firms announce inducement grants - drugdiscoverytrends.com Mon, 10 Apr 2023 07
- Does Your State Have a Gross Receipts Tax? - Tax Foundation ue, 14 May 2024 07
- BioWorld Cancer Index continues to decline amid broader market gains - BioWorld MedTech hu, 31 Oct 2024 07
- Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - TradingView Fri, 11 Oct 2024 07
- Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering - GlobeNewswire Mon, 01 Apr 2024 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for GRTS
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|